HIV

There are 25 papers on HIV in aging research: 3 trials and 16 observational studies in people, 5 reviews. The newest story, Oct 26, 2026: “HIV was not linked to an age-related blood condition in veterans”.

Disease

25 papers study it32 findings

5 new papers in 30 daysSee all 25 papers on HIV

“This open label trial finds that PWH have premature aging based on multiple biological and functional defects”
Supplementing Glycine and N-acetylcysteine (GlyNAC) in Aging HIV Patients Improves Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Endothelial Dysfunction, Insulin Resistance, Genotoxicity, Strength, and Cognition: Results of an Open-Label Clinical TrialBiomedicines2020doi:10.3390/biomedicines8100390
  • Human trial3
  • Humans16

Effects

8

Valvular calcium

no changein humans1OR 0.64

1 study
  1. HIV was not clearly linked with valvular calcium in humans (High cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartile) (OR 0.64, 95% CI 0.28–1.42).

    “HIV showed no significant association with coronary (OR 0.75 [95% CI 0.35-1.57]) or valvular (OR 0.64 [95% CI 0.28-1.42]) calcium.”

    HumansHigh cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartileheart valve50% females

    Vascular and Valvular Calcium Among High Cardiovascular Risk Kenyan Adults With and Without HIV: The ASANTE Study

    AHA Scientific Sessions 2026 abstract

Coronary artery calcium

no changein humans1OR 0.75

1 study
  1. HIV was not clearly linked with coronary artery calcium in humans (High cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartile) (OR 0.75, 95% CI 0.35–1.57).

    “HIV showed no significant association with coronary (OR 0.75 [95% CI 0.35-1.57]) or valvular (OR 0.64 [95% CI 0.28-1.42]) calcium.”

    HumansHigh cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartilecoronary artery50% females

    Vascular and Valvular Calcium Among High Cardiovascular Risk Kenyan Adults With and Without HIV: The ASANTE Study

    AHA Scientific Sessions 2026 abstract

Stroke

no changein humans1HR 0.98

1 study
  1. HIV was not clearly linked with stroke in humans (HR 0.98, 95% CI 0.62–1.54).

    “Stroke was similar between groups (HR 0.98, 95% CI 0.62–1.54, p=0.93).”

    HumansSustained viral suppression without viral blips on continuous antiretroviral therapy; compared with healthcare-engaged adults without HIV1 to 10 years post-indexn = 1,978

    Residual Cardiovascular Risk in People with HIV with Sustained Viral Suppression Without Viral Blips: A Propensity Score-Matched Retrospective Cohort Study

    AHA Scientific Sessions 2026 abstract

More on Stroke

Clonal hematopoiesis of indeterminate potential

no changein humans1OR 0.99

1 study
  1. HIV was not clearly linked with clonal hematopoiesis of indeterminate potential in humans (US veterans; multivariable-adjusted analysis) (OR 0.99, 95% CI 0.77–1.29).

    “HIV was not associated with the presence of CHIP in this older cohort of US veterans.”

    HumansUS veterans; multivariable-adjusted analysis

    HIV was not linked to an age-related blood condition in veterans

    ESC Congress 2026 abstract

More on Clonal hematopoiesis of indeterminate potential

Lower urinary tract symptoms

no changein humans1

1 study
  1. HIV was not clearly linked with lower urinary tract symptoms in humans.

    “There was no association of HIV with LUTS.”

    Humans

    Frailty Is Associated With Lower Urinary Tract Symptoms in Adults With and Without HIV

    Journal of the American Geriatrics Society

Anxiety

no changein humans1

1 study
  1. HIV was not clearly linked with anxiety in humans (compared with individuals without HIV).

    “with no differences in anxiety.”

    Humanscompared with individuals without HIV

    The present of aging with HIV: sociodemographic, psychosocial, and health-related differences between people living with HIV and people without HIV in an aging population in Houston, Texas

    AIDS care

More on Anxiety

Cellular senescence

upin humans1

1 study
  1. HIV induces cellular senescence in humans (perinatally infected, even with prompt start of cART).

    “Children infected perinatally show indications of immune aging or immune senescence significantly sooner than their uninfected counterparts, even with the prompt start of combination antiretroviral therapy (cART).”

    Reviewperinatally infected, even with prompt start of cART

    IMMUNE AGING IN THE YOUNG: CONSEQUENCES OF HIV-INDUCED SENESCENCE IN CHILDREN

    Universal Journal of Pharmaceutical Research

More on Cellular senescence

Bone health

downin humans1

1 study
  1. HIV impairs bone health in humans.

    “Risk factors contributing to poorer bone health include HIV, malnutrition and "inflammaging."”

    Review

    Disparities in the Prevalence of Osteoporosis and Osteopenia in Men and Women Living in Sub-Saharan Africa, the UK, and the USA

    Current osteoporosis reports

Associations

22

Frailty

upin humans2

2 studies
  1. HIV is associated with frailty in humans (living with HIV) (16.7% vs 6.3%).

    “Frailty was observed in 16.7% of participants with HIV versus 6.3% of adults without HIV (χ2(1) = 6.28, p = .012).”

    Humansliving with HIV

    Frailty in an Aging Population Living With and Without HIV: A Comparative Cross-sectional Analysis Using the Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight Scale in a Houston Urban Cohort

    The Journal of the Association of Nurses in AIDS Care : JANAC

  2. HIV is associated with frailty in humans (compared with individuals without HIV).

    “PLWH also had higher waist-to-hip ratios, greater frailty prevalence, higher depression scores, and lower happiness, with no differences in anxiety.”

    Humanscompared with individuals without HIV

    The present of aging with HIV: sociodemographic, psychosocial, and health-related differences between people living with HIV and people without HIV in an aging population in Houston, Texas

    AIDS care

Coronary plaque

upin humans1

1 study
  1. HIV is associated with coronary plaque in humans (aOR 5.5, 95% CI 1.7-25.8).

    “HIV seropositivity and age were significantly associated with the presence of plaque (aOR, 5.5 [95% CI, 1.7-25.8] and 21.7 [95% CI, 5.5-88] respectively).”

    Humansn = 186

    Early Identification of Atherosclerosis in People Living with HIV by Coronary Computed Tomography Angiography

    Diagnostics (Basel, Switzerland)

  2. HIV is linked with a higher risk of coronary plaque in humans (20% vs 7%, p = 0.015).

    “with 20% of individuals in PLWH showing plaque in the coronary arteries as detected by CTA, compared to 7% in the control group (p = 0.015).”

    Humansn = 186

    Early Identification of Atherosclerosis in People Living with HIV by Coronary Computed Tomography Angiography

    Diagnostics (Basel, Switzerland)

Blood pressure control

downin humans1

1 study
  1. HIV is associated with blood pressure control in humans (Adults with hypertension in Tanzania and Uganda) (BP control: 32.7% with HIV versus 46.9% without HIV; adjusted risk difference 14.5 percentage points (95% CI 9.5–19.5), favoring participants without HIV).

    “Blood pressure control was achieved in 32.7% (148/453) of PLHIV compared with 46.9% (909/1,938) of those without HIV”

    HumansAdults with hypertension in Tanzania and Uganda12 monthsn = 2,391

    Blood pressure control among adults with hypertension living with HIV and without HIV in Tanzania and Uganda: a secondary analysis of the INTE-AFRICA trial

    AIDS research and therapy

Aortic calcium

downin humans1OR 0.38

1 study
  1. HIV is associated with aortic calcium in humans (High cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartile) (OR 0.38, 95% CI 0.15–0.885; p = 0.03).

    “In a high cardiovascular risk East African cohort, calcified atherosclerosis was uncommon overall, and HIV was independently associated with lower aortic calcium.”

    HumansHigh cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartileaorta50% females

    Vascular and Valvular Calcium Among High Cardiovascular Risk Kenyan Adults With and Without HIV: The ASANTE Study

    AHA Scientific Sessions 2026 abstract

Composite vascular calcium

downin humans1OR 0.53

1 study
  1. HIV is associated with composite vascular calcium in humans (High cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartile) (OR 0.53, 95% CI 0.27–1.01; p = 0.06).

    “HIV trended toward inverse association with composite vascular calcium (OR 0.53 [95% CI 0.27-1.01], p = 0.06)”

    HumansHigh cardiovascular risk Kenyan adults; adjusted for PREVENT risk quartile50% females

    Vascular and Valvular Calcium Among High Cardiovascular Risk Kenyan Adults With and Without HIV: The ASANTE Study

    AHA Scientific Sessions 2026 abstract

Major adverse cardiovascular events

upin humans1HR 1.52

1 study
  1. HIV is associated with major adverse cardiovascular events in humans (HR 1.52, 95% CI 1.12–2.06).

    “Adults with HIV had higher all-cause mortality (HR 1.80, 95% CI 1.20 –2.70, p=0.004) and MACE outcomes (HR 1.52, 95% CI 1.12–2.06, p=0.007).”

    HumansSustained viral suppression without viral blips on continuous antiretroviral therapy; compared with healthcare-engaged adults without HIV1 to 10 years post-indexn = 1,978

    Residual Cardiovascular Risk in People with HIV with Sustained Viral Suppression Without Viral Blips: A Propensity Score-Matched Retrospective Cohort Study

    AHA Scientific Sessions 2026 abstract

Mortality

upin humans1HR 1.8

1 study
  1. HIV is associated with mortality in humans (HR 1.80, 95% CI 1.20–2.70).

    “Adults with HIV had higher all-cause mortality (HR 1.80, 95% CI 1.20 –2.70, p=0.004) and MACE outcomes (HR 1.52, 95% CI 1.12–2.06, p=0.007).”

    HumansSustained viral suppression without viral blips on continuous antiretroviral therapy; compared with healthcare-engaged adults without HIV1 to 10 years post-indexn = 1,978

    Residual Cardiovascular Risk in People with HIV with Sustained Viral Suppression Without Viral Blips: A Propensity Score-Matched Retrospective Cohort Study

    AHA Scientific Sessions 2026 abstract

Epigenetic age

upin humans1

1 study
  1. HIV is associated with epigenetic age in humans (HIV status comparison; HorvathAA, HannumAA, PhenoAA, and EEAA).

    “PWH had shorter aTL, lower MRI-BPAD, and higher Horvath age acceleration (HorvathAA), HannumAA, PhenoAA, and extrinsic epigenetic age acceleration (EEAA).”

    HumansHIV status comparison; HorvathAA, HannumAA, PhenoAA, and EEAAfemalesn = 238

    Biological aging markers in South African women with HIV and variable exposure to childhood maltreatment

    medRxivPreprint

More on Epigenetic age

MRI-based brain-predicted age difference

downin humans1

1 study
  1. HIV is associated with MRI-based brain-predicted age difference in humans (HIV status comparison).

    “PWH had shorter aTL, lower MRI-BPAD, and higher Horvath age acceleration (HorvathAA), HannumAA, PhenoAA, and extrinsic epigenetic age acceleration (EEAA).”

    HumansHIV status comparisonbrainfemalesn = 238

    Biological aging markers in South African women with HIV and variable exposure to childhood maltreatment

    medRxivPreprint

More on MRI-based brain-predicted age difference

Absolute telomere length

downin humans1

1 study
  1. HIV is associated with absolute telomere length in humans (HIV status comparison).

    “PWH had shorter aTL, lower MRI-BPAD, and higher Horvath age acceleration (HorvathAA), HannumAA, PhenoAA, and extrinsic epigenetic age acceleration (EEAA).”

    HumansHIV status comparisonfemalesn = 238

    Biological aging markers in South African women with HIV and variable exposure to childhood maltreatment

    medRxivPreprint

More on Absolute telomere length

Premature aging

upin humans1

1 study
  1. HIV is associated with premature aging in humans (compared with uninfected controls at baseline).

    “This open label trial finds that PWH have premature aging based on multiple biological and functional defects”

    Human trialcompared with uninfected controls at baseline

    Supplementing Glycine and N-acetylcysteine (GlyNAC) in Aging HIV Patients Improves Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Endothelial Dysfunction, Insulin Resistance, Genotoxicity, Strength, and Cognition: Results of an Open-Label Clinical Trial

    Biomedicines

All 22

Trial sponsors

Funding

492 grants since 2016

National Institute on Aging$128MNational Heart, Lung, and Blood Institute$151MNational Institute of Allergy and Infectious Diseases$66.9M

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 2Sep 2026: 0Oct 2026: 3Nov 2026: 314 papers in 12 months
ESC Congress 2026 Abstract

HIV was not linked to an age-related blood condition in veterans

The adjusted odds ratio was 0.99 for veterans with HIV versus those without; a value of one would mean no association.The adjusted odds ratio was 0.99 for veterans with HIV versus those without; a value of one would mean no association.

Cohort studyHIV

See all 25 papers on HIV